Видео ютуба по тегу Context Therapeutics

Context Therapeutics' Big Stock Sale Play: My Insider Look
Context Therapeutics' Big Stock Sale Play: My Insider Look
Context Therapeutics highlights data on ONA-XR and CLDN6 at AACR 2022. With Martin Lehr.
Context Therapeutics highlights data on ONA-XR and CLDN6 at AACR 2022. With Martin Lehr.
Context Therapeutics; Meet CEO Martin Lehr
Context Therapeutics; Meet CEO Martin Lehr
Context Therapeutics - Precision Oncology - $CNTX
Context Therapeutics - Precision Oncology - $CNTX
Context Therapeutics; Recapping 2022 & What to Look Forward to in 2023
Context Therapeutics; Recapping 2022 & What to Look Forward to in 2023
Up 93% This Year! Is Context Therapeutics (CNTX) the Next Big Runner? CNTX STOCK PODCAST TODAY PRICE
Up 93% This Year! Is Context Therapeutics (CNTX) the Next Big Runner? CNTX STOCK PODCAST TODAY PRICE
Context Therapeutics releases corporate priorities and pipeline milestones for 2023
Context Therapeutics releases corporate priorities and pipeline milestones for 2023
Context Therapeutics; Answering Viewer's Questions About the Company
Context Therapeutics; Answering Viewer's Questions About the Company
Biotech Breakout or Bust? | CNTX stock analysis | Context Therapeutics stock prediction?
Biotech Breakout or Bust? | CNTX stock analysis | Context Therapeutics stock prediction?
Context Therapeutics; What CEO Martin Lehr Looks for in Successful Bio-tech Companies
Context Therapeutics; What CEO Martin Lehr Looks for in Successful Bio-tech Companies
Context Therapeutics webinar: Claudin 6 x CD3 bispecific antibody data update
Context Therapeutics webinar: Claudin 6 x CD3 bispecific antibody data update
Gynecological Cancer Therapies With Context Therapeutics' Martin Lehr
Gynecological Cancer Therapies With Context Therapeutics' Martin Lehr
Context Therapeutics; Answering More Viewer's Questions
Context Therapeutics; Answering More Viewer's Questions
Martin Lehr, CEO/Co-Founder of Context Therapeutics Inc., talks about cancer treatments.
Martin Lehr, CEO/Co-Founder of Context Therapeutics Inc., talks about cancer treatments.
Context Therapeutics published in STAT Report on new cancer targets
Context Therapeutics published in STAT Report on new cancer targets
Context Therapeutics reports a 'tremendous' 2Q as it approaches first full-year as a listed company
Context Therapeutics reports a 'tremendous' 2Q as it approaches first full-year as a listed company
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
Martin Lehr, CEO/Co-Founder of Context Therapeutics Inc., talks about their female cancer drugs.
Martin Lehr, CEO/Co-Founder of Context Therapeutics Inc., talks about their female cancer drugs.